🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

1-year outcomes OPERA-TAVI registry finally out! 👉 No differences in mortality and re-hosp 👉Higher disabling stroke in Evolut PRO/PRO+ (2.6% vs. 0.4%). Selection bias? Real THV effect? It is time for more RCTs! #TAVI EuroIntervention Giuliano Costa eurointervention.pcronline.com/article/one-ye…

What you should know about the OPERA-#TAVI registry just published in EuroIntervention and presented at #PCRLV 2023! 🎥 Chiara De Biase interviewed first author Giuliano Costa

#PCRLV 2023 may be over, but the #science is here to stay⭐️ If busy again back home, here a handy overview of the results of the presented #TopLateBreakers ⤵️ Presented by: Philipp Lurz G.Nickenig, P.Nicz, @stolz_l G.Costa

Our recent study on PCI timing strategies in patients undergoing TAVI was among the most impactful articles in EuroIntervention 2023! Great collaborative work! This is a tribute to all co-workers involved in this project ! Marco Barbanti Giuliano Costa Michael Joner

x.com/JEscaned/statu… Davide Capodanno PCRonline 🫀

In the RE-ACCESS 2 Study unsuccessful coronary cannulation after #Evolut and #Acurate implanted with commissural alignment was 5.5%. Acurate still better than Evolut, but Remarkable improvement compared with RE-ACCESS.Commissural alignment in #TAVI matters JACC Journals

💥TAVR in Small Annuli: SAPIEN ULTRA vs. Evolut PRO JACC Journals 🌐A SMART Trial-like design in a Real-World TAVR Registry 🔗 doi.org/10.1016/j.jcin… Azeem Latib @MatteoMSturla GCosta Marco Barbanti Montefiore Health System Albert Einstein College of Medicine - Official ⏳ What will the SMART RCT show American College of Cardiology?

Self-expanding (SE) Evolut PRO vs balloon-expandable (BE) SAPIEN ULTRA in small annuli: 🔸 SE - superior hemodynamic performance (gradients, PPM) 🔸 BE - less PVL, PPI, stroke 📎 bit.ly/3vntMHB #JACCINT #vhdAS #TAVI

"RE-ACCESS 2" study reveals insights into coronary cannulation post-TAVR with self-expanding devices. 5.5% faced issues, mainly with Evolut THVs. Commissural alignment crucial! bit.ly/3vwb9l6 #JACCINT #Cardiology #TAVR #cvCAD

This propensity-score matched study may be a foretaste of the SMART trial that will be presented at ACC this week. Evolut PRO and SAPIEN ULTRA Performance in Small Aortic Annuli: The OPERA-TAVI Registry | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.…

A special day for me, my first Roland Garros semifinal, and to reach the ranking of world #1. Grateful for this moment, something we have worked very hard for, but the work doesn’t stop here, forza!!! 1️⃣🦊

Is there a simplified left atrial appendage closure pathway? Safety and efficacy of percutaneous closure without preprocedural imaging. A Research Letter Giuliano Costa george ramsay Claudio Sanfilippo Marco Barbanti #cardiotwitter #AHAJournals ahajrnls.org/3XDBKZb

Severe aortic wall thrombus is a strong predictor of embolic event and #stroke in transfemoral #TAVR #JACCINT Marc Bonnet @BrahimHarbaoui

Early discharge after uncomplicated TAVI could be the future standard, as Bagur et al. confirm its safety and feasibility. Tailored protocols and monitoring are key. Editorial perspective by Giuliano Costa Sofia Sammartino 👉👉 shorturl.at/f3gMA #TAVR #CardiologyInnovation

Mitral ViV replacement with S3U under local anaesthesia and no pacing. Immediate recovery and NDD! CTA planned and #Acunav ICE-guided trans-septal puncture #CVT #CataniaValveTheraphies Edwards TAVR Edwards Lifesciences Marco Barbanti

Lipoprotein (a) contributes to the development and progression of atherosclerotic cardiovascular disease, but awareness on its role and Lp(a) testing remain limited. Lp(a)-lowering drugs are a potential breakthrough to improve cardiovascular outcomes. shorturl.at/IyjFQ

Do you need more BE THV sizes?This analysis from the OPERA-TAVI registry showed that the BE Sapien 3 ULTRA Edwards Lifesciences had similar VARC-3 early safety and device success in optimal or intermediate sizing zones 👉 eurointervention.pcronline.com/article/balloo…

This analysis of the OPERA-TAVI registry found SAPIEN 3 Ultra implantation in intermediate sizing zones achieves comparable device success and safety to optimal sizing, with similar annular rupture rates. Giuliano Costa Marco Barbanti ow.ly/sXeU50Vb4RS #EAPCI #TAVI

Bicuspid Aortic Valve Disease & TAVI. Our new State-of-the-Art Review explores recent advances, challenges, and outcomes of TAVI in bicuspid valve. A must-read for clinicians and researchers! 🔗 academic.oup.com/eurheartj/adva… #Cardiology #TAVI #BicuspidAorticValve #HeartInnovation

Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation. Read this State-of-the-Art review published in #EHJ 👉 ow.ly/Tenm50VSnw7 Rocco Montone EHJ Editor-in-Chief